|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61P 25/24 | |||
| A61K 31/137 | |||
| A61M 11/00 | |||
| A61K 31/35 | |||
| C12Q 1/6883 |
| (11) | Number of the document | 3179993 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15831762.8 |
| Date of filing the European patent application | 2015-08-12 | |
| (97) | Date of publication of the European application | 2017-06-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/044830 |
| Date | 2015-08-12 |
| (87) | Number | WO 2016/025581 |
| Date | 2016-02-18 |
| (30) | Number | Date | Country code |
| 201462036896 P | 2014-08-13 | US |
| (72) |
LI, Qingqin S., US
DREVETS, Wayne C., US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | ESKETAMINE FOR USE IN A METHOD FOR THE TREATMENT OF DEPRESSION |
| ESKETAMINE FOR USE IN A METHOD FOR THE TREATMENT OF DEPRESSION |